Analysed ALMIRALL SA (LBTSF:OTCMKTS) News Sources
Almirall and Barcelona Supercomputing Center Expand Their Collaboration to Accelerate Innovation in Medical Dermatology
13-04-2026
yahoo.com
Lebrikizumab delivered long-term disease control for up to four years in patients with moderate-to-severe atopic dermatitis
27-03-2026
yahoo.com
AAD 2026: Almirall Presents New Clinical and Real‑world Evidence Across Atopic Dermatitis, Psoriasis, Actinic Keratosis and Acne
26-03-2026
yahoo.com
Almirall's 17th Skin Academy Highlights Scientific Advances in Inflammatory Skin Diseases and Skin Cancer, Patient-Reported Outcomes, and Holistic Care in Medical Dermatology
23-03-2026
yahoo.com
etherna's intratumoral mRNA/LNP platform advances to clinical testing in nonmelanoma skin cancer led by Almirall
24-02-2026
yahoo.com
Almirall SA (LBTSF) Q4 2025 Earnings Call Highlights: Strong Sales Growth and Strategic Investments
23-02-2026
yahoo.com
Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Rα, and Others | DelveInsight
19-02-2026
yahoo.com
What is the current price of ALMIRALL SA (LBTSF:OTCMKTS)?
The current price of ALMIRALL SA (LBTSF:OTCMKTS) is $0.
ALMIRALL SA (LBTSF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of ALMIRALL SA (LBTSF:OTCMKTS) since the previous trading day is $None.
ALMIRALL SA (LBTSF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of ALMIRALL SA (LBTSF:OTCMKTS) since the previous trading day is None%.
What is the most recent average sentiment score for ALMIRALL SA (LBTSF:OTCMKTS)?
The most recent average sentiment score for ALMIRALL SA (LBTSF:OTCMKTS) is 81 out of 100.
What is the most recent average sentiment for ALMIRALL SA (LBTSF:OTCMKTS)?
The most recent sentiment for ALMIRALL SA (LBTSF:OTCMKTS) is .
SEC-8K** Filing Available For ALMIRALL SA (LBTSF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.